Innovative Technologies 42Bio specializes in regenerative medicine using magnetic and biomolecule technologies to target unmet clinical and veterinary needs, presenting opportunities to collaborate on advanced biomedical solutions.
Emerging Market Presence With a focus on both human and veterinary health, 42Bio is positioned to expand its market share by introducing pioneering therapies and devices in niche segments of regenerative medicine.
Recent Development Focus Current projects include developing a magnetic separation device for COVID antibody capture, indicating a potential for partnerships in infectious disease diagnostics and therapeutic tools.
Growth Potential Though a small team, 42Bio's ongoing product development combined with a revenue range of up to 10 million dollars suggests opportunities for investors and partners looking for innovative biotech startups.
Funding Opportunities With recent funding of 256k, there are prospects for additional investments to accelerate research, commercialization, and scaling of their magnetic and biomolecule-based therapies.
$50M$100M
$1B$10B
$100M$250M
$50M$100M
$10M$25M42Bio, Inc. uses 8 technology products and services including WordPress, RSS, MySQL, and more. Explore 42Bio, Inc.'s tech stack below.
| 42Bio, Inc. Email Formats | Percentage |
| FLast@42bio.com | 50% |
| FLast@42bio.com | 50% |
Biotechnology ResearchUnited States2-10 Employees
42Bio’s mission is to develop and implement regenerative medicine technologies to advance human and veterinary health. The objective of 42Bio is to apply our magnetic and biomolecule technologies to address unmet needs in clinical and veterinary disease and injury. We aim to advance these technologies to make meaningful and rigorously-studied products that benefit both clinical and scientific communities.
Company Overview
Funding & Financials42Bio, Inc. has raised a total of $256K of funding over 1 rounds. Their latest funding round was raised on Aug 13, 2020 in the amount of $256K.
42Bio, Inc.'s revenue is estimated to be in the range of $1M$10M
Funding & Financials42Bio, Inc. has raised a total of $256K of funding over 1 rounds. Their latest funding round was raised on Aug 13, 2020 in the amount of $256K.
42Bio, Inc.'s revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com